Source link : https://newshealth.biz/health-news/apremilast-shows-sustained-benefit-for-genital-psoriasis/
A phase 3 trial shows that apremilast, an oral phosphodiesterase 4 inhibitor, improves symptoms, disease severity, and quality of life in patients with genital psoriasis over 32 weeks. Medscape Medical News Source link : https://www.medscape.com/viewarticle/apremilast-shows-sustained-benefit-genital-psoriasis-2025a1001024?src=rss Author : Publish date : 2025-12-23 02:36:00 Copyright for syndicated content belongs to the linked Source.
The post Apremilast Shows Sustained Benefit for Genital Psoriasis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-23 02:36:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8